ONLINE SPORTSBOOKS

Go Back   MajorWager Forums > MW - Online Sportsbooks > Stock Talk
Register FAQ Members List Calendar Search Today's Posts Mark Forums Read

Stock Talk Stock tips, opinions and analysis

Reply
 
LinkBack Thread Tools
  #1 (permalink)  
Old 03-02-2005, 01:14 AM
Bostongambler Bostongambler is offline
Five Star General
 
Join Date: May 2002
Posts: 36,390
Default BAZ


Tasker Products Begins Shipment of Its CloseCall(TM) Oral Care Product
February 24, 2005 08:41:00 AM ET


DANBURY, Conn., Feb. 24 /PRNewswire-FirstCall/ -- Tasker Capital Corp. (OTC Bulletin Board: TKER), a distributor and marketer of a licensed proprietary technology that is highly effective in inhibiting pathogenic bacteria, today announced that it has started shipment of its unique oral care product, CloseCall(TM), the first alcohol free, liquid breath freshener that is clinically proven to effectively eliminate bad breath odors caused from eating, smoking and drinking. Initial shipments were targeted for New England through a cohesive network of prominent direct-store delivery distributors.

One of its distributors, Clark Distribution Company (and its wholly owned subsidiary, g. housen and co.), is a highly successful, 25-year old company servicing greater New England. Richard Clark, president Clark Distribution, commented, "Early feedback from retailers and consumers indicate a high level of interest in CloseCall among target customers and consumers, as evidenced by our initial distribution successes with the on-premise bars and restaurant establishments and independent convenience and gas convenience outlets."

"We have established a credible reputation over our 25-year history and, as a result, are very selective about what product lines and brands we add to our portfolio," added Kevin Watterson, president of g.housen. "We are very excited about offering a unique item like CloseCall(TM) to our customers."

Tasker intends to expand distribution of CloseCall(TM) nationwide by this summer through a team of established distributors including CBS (a national distributor based in Cleveland), Great States Distributors, Power Distributing, Intrimex Trading and Major Brands. As nationwide distribution unfolds over the coming months, the Company intends to closely monitor consumer reception to further validate its product marketing strategy.

"Our marketing team conducted numerous consumer field tests to validate the effectiveness of CloseCall(TM). Test participants were fascinated by its capacity to eliminate tough breath odors driven by the consumption of garlic, onions, tobacco products, coffee and alcohol. Because of its unique, patented technology that removes germs and bacteria in the mouth, throat and upper respiratory tract, CloseCall(TM) promotes clean breath for extended periods," commented Barbara Longchamp, Tasker's vice president of oral care products.

Bob Appleby, Tasker's president and CEO, added, "Our marketing team, headed by Barbara, has carefully mapped out a flexible strategy to introduce CloseCall(TM). Packaging concepts, flavors, colors and marketing venues were methodically examined to determine the optimum market introduction of an oral hygiene product that we believe could revolutionize the industry. Local results from testing in area bars and restaurants demonstrated that the brand positioning speaks to the target audience and has generated consumer awareness, trial and repeat purchases."

About Tasker Products

Tasker Products is a manufacturer, distributor and marketer of products using a unique, licensed patented process that utilizes a highly charged, acidified, yet stable and safe solution that enables copper sulfate, widely known for its bacteriostatic properties to remain active throughout a wide range of pH values. The company is continuing its clinical research and development of future products in the oral care, food processing, skin care and pet products industries. Presently the company markets CloseCall(TM), the world's first clinically proven anti-microbial oral hygiene breath drink. Tasker Capital Corp. is headquartered in Danbury, Connecticut. To be added to the news distribution list or to present any questions, send an email to tasker@wallstreetir.com. Additional information about Tasker is also available at www.taskerproducts.com

This release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statement. Actual future results and trends may differ materially from those made in or suggested by any forward-looking statements due to a variety of factors, including, for example, our ability to compete with other products in our space; the risk of unfavorable federal regulation; and the fact that our status as a development stage company makes our future unclear. Consequently you should not place undue reliance on these forward-looking statements. We discuss many of these and other risks and uncertainties in greater detail under the section entitled, "Risk Factors That May Affect Future Results" in Item 1 of the Company's Current Report on Form 10-KSB as filed with SEC.

Investor Contact:

Joseph M. Zappulla
Wall Street Investor Relations
212-681-4100
2005 PRNewswire

Back to Recent News
advertisement



Protect your family
Get free
life insurance quotes


Went up a little on Tues. and again in after hours



Try MSN Internet Software for FREE!
MSN Home | My MSN | Hotmail | Shopping | Money | People & Chat | Search
Feedback | Help

__________________
Let hatred turn into friendship because of your existence.
Reply With Quote
  #2 (permalink)  
Old 03-02-2005, 01:20 AM
Bostongambler Bostongambler is offline
Five Star General
 
Join Date: May 2002
Posts: 36,390
Default RE: BAZ

Tasker Capital Signs Letter of Intent to Acquire Certain Assets of pHarlo Citrus Technology, Indian River Labs and Coast to Coast Labs
February 22, 2005 11:31:00 AM ET


* Tasker to acquire the utility patents for currently marketed products and expanded product line, on a worldwide basis

* Proposed acquisition will transform Tasker from a marketing company to
a multi-product, global technology company
* Tasker will also acquire two production facilities allowing it to
manufacture its products and maintain its own quality control program
DANBURY, Conn., Feb. 22 /PRNewswire-FirstCall/ -- Tasker Capital Corp. (OTC Bulletin Board: TKER), a distributor and marketer of licensed proprietary technology that is highly effective in inhibiting pathogenic bacteria, today announced that it has outlined terms for the purchase, through a stock and cash transaction, of certain assets of pHarlo Citrus Technologies ("pHarlo"), the creator of the pHarlo technology; Indian River Labs ("IRL"), the blender of pHarlo concentrate; and Coast to Coast Labs, a marketing company with strong synergies to Tasker's existing client base.

The completion of the transaction is subject to approval by Tasker's Board of Directors, completion of satisfactory due diligence by Tasker, and the negotiation of definitive transaction documents. Tasker began its business due diligence late in the fourth quarter of 2004 and legal due diligence has recently commenced, both of which are expected to be completed over the next several weeks.

Tasker currently has a number of exclusive license agreements with pHarlo to market its patented technology. Management decided to strengthen Tasker's control of both the source and the methods of manufacture of these products. Management believes by acquiring the worldwide rights to the patents it will enable the Company to capitalize on a multitude of new potential market opportunities throughout the world. As part of the proposed acquisition, Tasker will secure the rights to a number of new product areas that it believes offers significant upside potential and may potentially strengthen Tasker's relationships with targeted customers. Additionally, the proposed transaction would include the rights to develop pHarlo's water treatment technology, which Tasker would market it to municipalities and water supply companies, worldwide.

The underlying, patent-protected technology was developed over several years of extensive research and development efforts. Generally, the technology is utilized to produce a range of highly charged, acidified, yet stable and safe solutions that enable copper sulfate to remain active throughout a wide band of pH values. Copper Sulfate is widely known for its bacteriostatic properties and is "generally recognized as safe" ("GRAS") by the Food and Drug Administration.

The applications for this unique technology are diverse. Currently, the Company has developed products to reduce levels of bacteria in poultry processing and intends to expand its food processing line into other areas such as meat, fish, eggs, vegetables and fruit. Potential developments focus on the control of bacteria to promote fresher, safer products with longer shelf lives.

Under the terms of the Letter of Intent, negotiations, which began late in the fourth quarter of 2004, Tasker will pay cash totaling $2,178,000 and options to purchase a total of 19,920,000 shares of Tasker common stock (potential proceeds from the exercise of the options are estimated at $4,917,500). Tasker will also assume up to $5,310,900 of tax liabilities of the selling parties. The majority of the options will vest over a two year period, but could vest earlier if certain revenue growth milestones are achieved or if other events occur, such as the departure from the Company of certain key executives. The balance of the options will vest at the closing of the transaction, should it occur. In addition, Tasker has offered two-year contracts to each of IRL's, Coast to Coast's and pHarlo's employees at agreed upon salaries to ensure their continued participation.

Robert Appleby, Tasker's president and CEO, commented on the pending transaction, "The combination of our entities is a natural progression of our relationship. We have worked very closely with IRL and pHarlo over the last year to identify products and markets for their unique technology under licensing agreements. It became clearer that a closer relationship was needed to more effectively advance potential applications to marketable products. Because of our close relationship, the assimilation period will be almost immediate." Mr. Appleby continued, "The proposed consolidation of our entities offers numerous potential benefits to our shareholders. Aside from the expanded geographical markets and product lines, the combined entity will retain revenues that would have been paid to IRL and pHarlo under the original licensing arrangements."

David Dickinson, pHarlo Citrus Technologies' president, commented, "Tasker has done a commendable job establishing markets, packaging products and developing business models for the pHarlo technology. We have worked very closely with them over the last year to the extent it seemed as one company. The progression of this relationship into one consolidated entity will further free-up our time to focus on inventing more uses for our technology and developing new technologies." David Creasy, Indian River Labs' president added, "Tasker's recent additions to its professional staff have provided crucial support to the recognition and application of our technology. We, as scientists, are far more productive working in a corroborative infrastructure environment that enables us to focus on research and development. When, as planned, the companies merge forces, the combination will be much more conducive to maximizing the potential for our technology."

Mr. Appleby concluded, "We all consider ourselves fortunate to be involved with the introduction of a new technology that has so many potentially beneficial applications. The uniqueness of this technology and its apparent capabilities has helped us attract well recognized industry leaders as potential customers."

About Tasker Products

Tasker Products is a manufacturer, distributor and marketer of products using a unique, licensed patented process that utilizes a highly charged, acidified, yet stable and safe solution that enables copper sulfate, widely known for its bacteriostatic properties to remain active throughout a wide range of pH values. The company is continuing its clinical research and development of future products in the oral care, food processing, skin care and pet products industries. Presently the company markets Close Call(TM), the world's first clinically proven anti-microbial oral hygiene breath drink. Tasker Capital Corp. is headquartered in Danbury, Connecticut. To be added to the news distribution list, send an e-mail to tasker@wallstreetir.com. Additional information about Tasker is available at www.taskerproducts.com.

This release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statement. Actual future results and trends may differ materially from those made in or suggested by any forward-looking statements due to a variety of factors, including, for example, our ability to compete with other products in our space; the risk of unfavorable federal regulation; and the fact that our status as a development stage company makes our future unclear. Consequently you should not place undue reliance on these forward-looking statements. The proposed transaction may or may not close based on the findings of the business and legal due diligence and the decision by Tasker Capital's Board of Directors. If the transaction does close, the Company may find that the combination does not yield the anticipated synergies or benefits. We discuss many of these and other risks and uncertainties in greater detail under the section entitled, "Risk Factors That May Affect Future Results" in Item 1 of the Company's Current Report on Form 10-KSB as filed with SEC.

Investor Contact:

Joseph M. Zappulla
Wall Street Investor Relations
212-681-4100
jzappulla@wallstreetir.com
2005 PRNewswire

Back to Recent News
advertisement



Track your stocks
Use the web's best
portfolio manager






Try MSN Internet Software for FREE!
MSN Home | My MSN | Hotmail | Shopping | Money | People & Chat | Search
Feedback | Help



2005 Microsoft Corporation. All rights reserved. Terms of Use Advertise MSN Privacy Statement GetNetWise Anti-Spam Policy
__________________
Let hatred turn into friendship because of your existence.
Reply With Quote
  #3 (permalink)  
Old 03-02-2005, 08:05 AM
bazanster2 bazanster2 is offline
Two Star General
 
Join Date: Jul 2001
Posts: 7,909
Default RE:BAZ

BG

Thanks, I'll get to it was soon as possible.
Really tired right now. it shows in in my calls on the Street and the NBA.
Just gotta to hang tough and try to get a second wind.
Will check out the particualars as soon as possible.
Here are some interesting findings related to this subject.

thanks and wishing you the best,

baz

================================================== ================

Can genetically engineered bacteria cure tooth decay?

by Michael Rosenwald

July 2004

Kids get cavities. Dentists fill them. It's a fairly old arrangement, but it may soon come to an end if cavities go the way
of smallpox. Jeffrey Hillman's company, Oragenics, has patented a simple swab of bacteria that when wiped across a set of
teeth will (allegedly) grant a lifetime of protection from tooth decay. By this fall, Hillman, a dental researcher at the
University of Florida, will begin testing the new strain on 15 to 30 volunteers.

Normally, bacteria called Streptococcus mutans grow on human teeth and convert sugar into lactic acid, which rots enamel.
Hillman engineered a strain of S. mutans that doesn't produce lactic acid; instead, it carries an antibiotic that helps
it displace the indigenous cavity-inducing strain. "The dentist will apply our bacteria and then tell the patient to go
home and eat sugar," Hillman says. As luck would have it, Tootsie Rolls, lollipops, et al. help to colonize the new strain,
but instead of creating a cavity the sugar helps form a tooth security guard, thus revolutionizing the practice of modern
dentistry. "I think that's a fair way to put it," says Kenneth Burrell, senior director of the American Dental Association
Council on Scientific Affairs. But there could be a hitch with the FDA: Hillman is not sure whether patients can transfer
the new strain to others with, say, just a kiss. Hillman is confident there will be no "horizontal transmission,"
but just to be sure, the spouses of Phase I testers will be monitored. If the strain stays put, it could go commercial
within five to six years.

================================================== ===================================
Who Knew Cranberries Had This Effect?

Can't brush your teeth at work? Just drink cranberry juice instead. Researchers from the University of Rochester have
concluded that cranberry juice may help prevent certain oral health problems, including diseases of the gums and teeth,
reports Medical News Today.

Cranberry juice does this by preventing Streptococcus mutans bacteria from sticking to teeth. In order for dental plaque
to build up on the teeth--the first step toward cavities and gum disease--bacteria has to stick to the teeth.
If the bacteria can't adhere, plaque can't develop.

Led by Dr. Hyun Koo, the research team evaluated the effectiveness of cranberry juice based on two daily glasses of
a beverage that contained 25 percent cranberry juice. That much juice inhibited the bacteria from binding to an
artificial tooth in the lab by 67 to 85 percent. Next up? Look for dental floss and toothpaste made with cranberries.

Cranberries may be the new health food. Their benefits are so extensive that you might want to make them a regular
part of your diet:

* They prevent urinary tract infections.
* They prevent most stomach ulcers.
* Their high level of antioxidants protect the heart from cardiovascular disease.
* A study from Winona State University showed that low-calorie cranberry juice decreases total blood cholesterol.
* A study from the University of Massachusetts-Dartmouth showed that cranberries may reduce the severity of a stroke
in its early stages, the point at which the most damage occurs.
* The antioxidants in cranberries may also help prevent certain types of cancers. While data is preliminary,
researchers are interested in cranberries' role in inhibiting the growth of oral, prostate, colon, breast,
cervical, lung and leukemia cancer cells, reports Medical News Today.

------------------------------------------------------------------------------------------------------------------------------------------

There as been a direct link between dental plaque and heart attacks.




Reply With Quote
  #4 (permalink)  
Old 03-02-2005, 08:20 AM
bazanster2 bazanster2 is offline
Two Star General
 
Join Date: Jul 2001
Posts: 7,909
Default RE:BAZ

WOW,

From 5 cents to $4.51. Quite an impressive run and with good reason.
As for getting in long term with a product this promising, one can't get in
soon enough. However, would image that at some point, the stock
intial surge corrects. For that, as usual, would watch the moving averages
and volume averages.
This one looks like a good one.
Will have to look at the finacials and stock allocations.

Appreciate this one,

baz
[img]i/expressions/face-icon-small-smile.gif[/img]
Reply With Quote
  #5 (permalink)  
Old 03-10-2005, 02:59 PM
bazanster2 bazanster2 is offline
Two Star General
 
Join Date: Jul 2001
Posts: 7,909
Default RE:BAZ

Possibility of Growing New Teeth Envisioned

Wed Mar 9, 3:22 PM ET Health - Reuters


By Alison McCook

NEW YORK (Reuters Health) - We may not be very far away from a time when dentists offer to help people
with damaged or missing teeth grow new ones, according to new research presented on Wednesday.
A series of presentations at a dental meeting demonstrate that techniques using stem cells and gene
therapy to regenerate teeth are producing promising results, suggesting this technique may not be far off.
"I think it's looking like quite an exciting technology for the near future," said Dr. Tony Smith, editor of the
Journal of Dental Research, who was not involved in any of the newest studies.
Smith explained that the presentations describe techniques that enable dentists to coax existing teeth
into repairing and regenerating themselves, and techniques where dentists can "start from scratch."
Clearly, techniques that involve adding new tissue to already-existing teeth are "probably a bit closer
on the horizon," perhaps within a "handful of years," Smith predicted. Techniques that grow teeth from
scratch will likely take at least another 10 years to perfect, he added.
In some instances, researchers are trying to reprogram cells in the mouth to behave like
tooth-growing cells, convincing them they have to produce new teeth, Smith explained.
Other techniques being explored involve using stem cells, which have the potential to become
any type of cell or tissue. In one study being presented at the meeting, researchers successfully
extracted stem cells from the pulp of adult teeth, Smith said. The next step is to examine whether
it's possible to use these teeth to regenerate new dental tissue, he said.
Other research being unveiled describes tests of different approaches to select stem cells from pulp,
and all shows "different degrees of success," Smith said.
These techniques may one day help people whose teeth have decayed from very bad cavities,
who have lost teeth in an accident, or whose teeth have worn down from acid or hard brushing,
among other conditions, he predicted.
The findings are being presented Wednesday, Thursday and Saturday during the 83rd General
Session of the International Association for Dental Research in Baltimore, Maryland.






Reply With Quote
Reply


Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On



All times are GMT -4. The time now is 06:53 AM.

Please be advised that if you are wagering over the internet, this is illegal in many jurisdictions. A wagering site may be operating legally at their location but it may still be illegal for you to wager from your location. We suggest you check on the legal situation from any jurisdiction in which you may wager.
 

Search Engine Optimization by vBSEO 3.0.0 RC6